definiens: shall mean [ * * * * ] 1.6 shall mean any information exchanged between Luxna and Aligos, either directly or indirectly, orally or in writing or other tangible medium, regarding the Licensed Rights or this Agreement and/or the performance of either party h ereunder, including without limitation ( a ) intellectual property, such as, but not limited to, patents, patent applications, 1 copyrights, copyright applications, and trade secrets and/or ( b ) confidential information, including without limitation ( i ) information regarding physical or chemical or biological materials ( such as, but not limited to, reagents, gene sequences, nucleic acids, cell lines, media, antibodies, compounds, c -DNAs, antisense oligonucleotides, proteins and vectors ) and techniques for their handling and use ; ( ii ) information regarding ideas, technology and processes ( such as, but not limited to, assays, techniques, sketches, schematics, drawings, works of authorship, models, designs, inventions, know -how, technical documentation, equipment, algorithms, software programs, software source documents, formulae ) ; ( iii ) information concerning or resulting from research and development projects and other projects ( such as, but not limited to, preclinical and clinical data, design details a nd specifications, engineering information, and works in process ) ; ( iv ) business and financial information ( such as, but not limited to, current, future, and proposed products and services, financial information and models, information relating to procurem ent requirements, purchasing, manufacturing, customer lists, product plans, product ideas, business strategies, marketing or business plans, financial or personnel matters, investors, employees, business and contractual relationships, business forecasts, s ales and merchandising, and information regarding third parties, suppliers, customers, employees, investors or facilities ) ; ( v ) any information created using the foregoing Confidential Information ; and ( vi ) any other information which is designated by eith er party as or some similar designation, other than that which : ( a ) is already in the recipient party ’s possession at the time of disclosure as evidenced by the recipient party ’s contemporaneous written records ; ( b ) is or later becomes part of the public domain through no fault of the recipient party ; ( c ) is received from a third party having no obligations of confidentiality to the disclosing party ; or ( d ) is independently developed by the recipient p arty without the use of or reliance upon Confidential Information as evidenced by the recipient party ’s contemporaneous written records